U.S. federal trademark · Serial No. 88624847 · Reg. No. 7626610
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of fibrosis, cirrhosis, liver disease, kidney disease, dermatological conditions and diseases, autoimmune diseases, inflammatory diseases, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), and Capsular contracture; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of fibrosis, cirrhosis, liver disease, kidney disease, dermatological conditions and diseases, autoimmune diseases, inflammatory diseases, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH), and Capsular contracture; none of the foregoing for or related to the treatment of male erectile dysfunction
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.